Iovance Biotherapeutics (IOVA) Earnings Date & Reports

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

IOVA is expected to report earnings to fall 31.32% to -13 cents per share on August 06

Iovance Biotherapeutics IOVA Stock Earnings Reports

Q2'26

Est.

$-0.13

Q1'26

Missed

by $0.05

Q4'25

Missed

by $0.01

Q3'25

Beat

by $0.01

Q2'25

Missed

by $0.05

The last earnings report on May 07 showed earnings per share of -18 cents, missing the estimate of -14 cents. With 6.23M shares outstanding, the current market capitalization sits at 2.23B.

View a ticker or compare two or three

IOVA

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days